Expanded Access to ABBV-400
Sponsor: AbbVie
ClinicalTrials ID:NCT05982873
This expanded access program provides ABBV-400, an investigational IV infusion, to eligible participants not qualified for ABBV-400 clinical trials. A medical doctor must assess the potential benefits and risks based on the patient's medical history and program criteria. Availability is subject to territory eligibility and local regulatory approval.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-400 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Eligibility Criteria
Inclusion Criteria
- The participant must not be eligible for an ABBV-400 clinical trial.
Get This Program In Your Inbox
You can sign up and apply your patients for this program.